{
    "SPADE_N_13918": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13918",
            "Peptide Name": "Nisin S (natural AMPs; lantibiotic, class 1 bacteriocin, Gram-positive bacteria, prokaryotes; UCSS1b)",
            "Source": "Ligilactobacillus salivariusP1CEA3, isolated from the gastrointestinal tract (GIT); pig microbiota:Gut, symbiont bacteria",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "ITSYSLCTPGCKTGALMGCTMKTASCGCHVHISK",
            "Sequence Length": 34,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 3491.16,
            "PI": 8.76,
            "Hydrophobicity": 0.34,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Sevillano E, Peña N, Lafuente I, Cintas LM, Muñoz-Atienza E, Hernández PE, Borrero J. 2023",
                    "Reference": "Int J Mol Sci. 2023 Apr 6;24(7):6813. doi: 10.3390/ijms24076813.Pub-Med.",
                    "Title": "Nisin S, a Novel Nisin Variant Produced by Ligilactobacillus salivarius P1CEA3."
                }
            ],
            "Frequent Amino Acids": "CTG",
            "Absent Amino Acids": "DEFNOQRUW",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 11,
            "Polar Residues": 23,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "Net Charge": 5,
            "Comments": "Discovery: detected in supernatant and purified in the same way as nisin A.Sequence analysis: APD analysis reveals this sequence is most similar (79.41%) toNisin AC: 15%: T: 15% G: 12%. The structure is proposed to be the same as nisin A except for some amino acid changes, inlcuding I4Y, N20T, T25S, H27G, S29H, I30V, and V32I.Activity: inhibition zone assay: active against indicator Gram-positive strains E. faecalis 12Ep11 (+++), L. seeligeri CECT 917 (+++), L. monocytogenes CECT 4032 (++), L. innocua CECT 910 (++), S. aureus ZTA11/00117ST or DICM10/00243 (++), S. epidermidis DICM15/00071 (++), S. pseudintermedius ICM21/02217 (++), S. suis CECT 958 or serotype 1 DICM10/01182–1C (++), S. iniae ATCC 29178 (++), S. agalactiae DICM11/00863 (+++), S. dysgalactiae VSE16/01903A (+++), S. equi zooepidermicus VSE16/00697 (++), C. ulcerans ICM19/00922–1B (++), C. pseudotuberculosis Cam2 (++), C.  mastitidis INDA2 (++), C.bovis AM3 (-), B.cereus ICM17/00252 (-), T. pyogenes ICM17/02091–1 (++), E. rhusiopathiae ICM21/01900 (+++), C. perfringens DICM15/00067–5A (+++), E. coli DH5alpha (+), and S.paratyphi CECT 554 (-) Note -= no inhibition, += <5 mm, ++= 5–10 mm, +++= >10 mm.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14082",
                    "Similarity": 0.9090909090909091,
                    "Sequence": "ITSISLCTPGCKTGALMGCNMK"
                },
                {
                    "SPADE_ID": "SPADE_N_00044",
                    "Similarity": 0.8235294117647058,
                    "Sequence": "ITSISLCTPGCKTGALMGCNMKTATCNCSVHVSK"
                },
                {
                    "SPADE_ID": "SPADE_N_06114",
                    "Similarity": 0.8235294117647058,
                    "Sequence": "MSTKDFNLDLVSVSKKDSGASPRITSISLCTPGCKTGALMGCNMKTATCNCSVHVSK"
                }
            ]
        }
    }
}